Literature DB >> 11338575

Direct profiling of multiple enzyme activities in human cell lysates by affinity chromatography/electrospray ionization mass spectrometry: application to clinical enzymology.

S A Gerber1, C R Scott, F Turecek, M H Gelb.   

Abstract

We describe a new method for enzyme analysis using affinity capture followed by electrospray ionization mass spectrometry (ACESIMS) for the quantitative determination of the initial velocities of four heparin-modifying enzymes. These enzymes, when defective in affected children, lead to the lysosomal storage disease known as Sanfilippo syndrome. The method relies on substrates and internal standards conjugated to the molecular handle biotin via a heavy isotope-encodable, mass-adjustable linker. Reaction velocities of the Sanfilippo enzymes in a crude lysate prepared from as little as 2500 human skin fibroblasts can be determined. In addition, the ACESIMS method is widely applicable to the simultaneous analysis of multiple enzymes in a complex biological sample by a single analytical technique and will thus serve as a useful tool in basic and clinical biomedical research.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11338575     DOI: 10.1021/ac0100650

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  9 in total

1.  Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening.

Authors:  Yijun Li; C Ronald Scott; Nestor A Chamoles; Ahmad Ghavami; B Mario Pinto; Frantisek Turecek; Michael H Gelb
Journal:  Clin Chem       Date:  2004-08-03       Impact factor: 8.327

Review 2.  Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases.

Authors:  Wulf Röschinger; Bernhard Olgemöller; Ralph Fingerhut; Bernhard Liebl; Adelbert A Roscher
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

3.  New substrates and enzyme assays for the detection of mucopolysaccharidosis III (Sanfilippo Syndrome) types A, B, C, and D by tandem mass spectrometry.

Authors:  Brian J Wolfe; Farideh Ghomashchi; Tim Kim; Cynthia A Abam; Martin Sadilek; Rhona Jack; Jerry N Thompson; C Ronald Scott; Michael H Gelb; Frantisek Turecek
Journal:  Bioconjug Chem       Date:  2012-03-09       Impact factor: 4.774

Review 4.  Newborn screening of mucopolysaccharidoses: past, present, and future.

Authors:  Nivethitha Arunkumar; Thomas J Langan; Molly Stapleton; Francyne Kubaski; Robert W Mason; Rajendra Singh; Hironori Kobayashi; Seiji Yamaguchi; Yasuyuki Suzuki; Kenji Orii; Tadao Orii; Toshiyuki Fukao; Shunji Tomatsu
Journal:  J Hum Genet       Date:  2020-04-10       Impact factor: 3.172

5.  Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders.

Authors:  Michael H Gelb; Frantisek Turecek; C Ron Scott; Nestor A Chamoles
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

6.  Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).

Authors:  Trisha A Duffey; Martin Sadilek; C Ronald Scott; Frantisek Turecek; Michael H Gelb
Journal:  Anal Chem       Date:  2010-10-20       Impact factor: 6.986

7.  Simultaneous kinetic characterization of multiple protein forms by top down mass spectrometry.

Authors:  Huili Zhai; Pieter C Dorrestein; Abhishek Chatterjee; Tadhg P Begley; Fred W McLafferty
Journal:  J Am Soc Mass Spectrom       Date:  2005-07       Impact factor: 3.109

8.  In situ and multisubstrate detection of elastase enzymatic activity external to microdialysis sampling probes using LC-ESI-MS.

Authors:  Ying Wang; Dmitri V Zagorevski; Julie A Stenken
Journal:  Anal Chem       Date:  2008-02-16       Impact factor: 6.986

9.  A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells.

Authors:  Victor Mauri; Parisa Lotfi; Laura Segatori; Marco Sardiello
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.